Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis.

Quraishi MNN, Yalchin M, Blackwell C, Segal J, Sharma N, Hawkey P, McCune V, Hart AL, Gaya D, Ives NJ, Magill L, Loi S, Hewitt C, Gerasimidis K, Loman NJ, Hansen R, McMullan C, Mathers J, Quince C, Crees N, Iqbal T.

BMJ Open. 2019 Nov 11;9(11):e030659. doi: 10.1136/bmjopen-2019-030659.

PMID:
31719078
2.

Editorial: how safe is it to administer the BCG vaccination to babies exposed to anti-TNFα medications antenatally?

Bouri S, Hart AL.

Aliment Pharmacol Ther. 2019 Dec;50(11-12):1239. doi: 10.1111/apt.15535. No abstract available.

3.

Deficient Resident Memory T-Cell and Cd8 T-Cell Response to Commensals in Inflammatory Bowel Disease.

Noble A, Durant L, Hoyles L, McCartney AL, Man R, Segal J, Costello SP, Hendy P, Reddi D, Bouri S, Lim DNF, Pring T, O'Connor MJ, Datt P, Wilson A, Arebi N, Akbar A, Hart AL, Carding SR, Knight SC.

J Crohns Colitis. 2019 Oct 26. pii: jjz175. doi: 10.1093/ecco-jcc/jjz175. [Epub ahead of print]

PMID:
31665283
4.

Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.

Taylor SA, Mallett S, Bhatnagar G, Morris S, Quinn L, Tomini F, Miles A, Baldwin-Cleland R, Bloom S, Gupta A, Hamlin PJ, Hart AL, Higginson A, Jacobs I, McCartney S, Murray CD, Plumb AA, Pollok RC, Rodriguez-Justo M, Shabir Z, Slater A, Tolan D, Travis S, Windsor A, Wylie P, Zealley I, Halligan S.

Health Technol Assess. 2019 Aug;23(42):1-162. doi: 10.3310/hta23420.

5.

The gut virome: the 'missing link' between gut bacteria and host immunity?

Mukhopadhya I, Segal JP, Carding SR, Hart AL, Hold GL.

Therap Adv Gastroenterol. 2019 Mar 25;12:1756284819836620. doi: 10.1177/1756284819836620. eCollection 2019. Review.

6.

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.

Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group.

Lancet Gastroenterol Hepatol. 2019 May;4(5):341-353. doi: 10.1016/S2468-1253(19)30012-3. Epub 2019 Feb 27.

PMID:
30824404
7.

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.

Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, Ananthakrishnan AN, Barrett JC, Beaugerie L, Bewshea CM, Cole AT, Cummings FR, Daly MJ, Ellul P, Fedorak RN, Festen EAM, Florin TH, Gaya DR, Halfvarson J, Hart AL, Heerasing NM, Hendy P, Irving PM, Jones SE, Koskela J, Lindsay JO, Mansfield JC, McGovern D, Parkes M, Pollok RCG, Ramakrishnan S, Rampton DS, Rivas MA, Russell RK, Schultz M, Sebastian S, Seksik P, Singh A, So K, Sokol H, Subramaniam K, Todd A, Annese V, Weersma RK, Xavier R, Ward R, Weedon MN, Goodhand JR, Kennedy NA, Ahmad T; IBD Pharmacogenetics Study Group.

JAMA. 2019 Feb 26;321(8):773-785. doi: 10.1001/jama.2019.0709. Erratum in: JAMA. 2019 Apr 23;321(16):1636.

8.

Recurrent oral squamous cell carcinoma-incorporating advance care planning in education and practice.

Munz SM, Helman JI, Tiner MK, Hart AL.

Spec Care Dentist. 2019 Mar;39(2):246-251. doi: 10.1111/scd.12369. Epub 2019 Feb 12.

PMID:
30748030
9.

The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease.

Segal JP, Mullish BH, Quraishi MN, Acharjee A, Williams HRT, Iqbal T, Hart AL, Marchesi JR.

Therap Adv Gastroenterol. 2019 Jan 24;12:1756284818822250. doi: 10.1177/1756284818822250. eCollection 2019. Review.

10.

Biological therapy for the treatment of prepouch ileitis: a retrospective observational study from three centers.

Segal JP, Rottoli M, Felwick RK, Worley GH, McLaughlin SD, Vallicelli C, Bassett P, Faiz OD, Hart AL, Clark SK.

Clin Exp Gastroenterol. 2018 Dec 11;11:461-465. doi: 10.2147/CEG.S179418. eCollection 2018.

11.

Narrative medicine applications for patient identity and quality of life in ventricular assist device (VAD) patients.

Slocum RB, Hart AL, Guglin ME.

Heart Lung. 2019 Jan;48(1):18-21. doi: 10.1016/j.hrtlng.2018.09.013. Epub 2018 Oct 25.

PMID:
30539722
12.

Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective study.

Segal JP, Penez L, Mohsen Elkady S, Worley GHT, McLaughlin SD, Mullish BH, Quraishi MN, Ding NS, Glyn T, Kandiah K, Samaan MA, Irving PM, Faiz OD, Clark SK, Hart AL.

Scand J Gastroenterol. 2018 Sep;53(9):1051-1058. doi: 10.1080/00365521.2018.1496271. Epub 2018 Sep 29.

13.

Standardising assessment and documentation of pouchoscopy.

van der Ploeg VA, Maeda Y, Faiz OD, Hart AL, Clark SK.

Frontline Gastroenterol. 2018 Oct;9(4):309-314. doi: 10.1136/flgastro-2017-100928. Epub 2018 Mar 13.

14.

How Quickly Do Inflammatory Bowel Disease Medications Really Work?

Bouri S, Hart AL.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):34-35. doi: 10.1016/j.cgh.2018.09.021. Epub 2018 Sep 19. No abstract available.

PMID:
30243762
15.

The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort study.

Sebastian S, Black C, Pugliese D, Armuzzi A, Sahnan K, Elkady SM, Katsanos KH, Christodoulou DK, Selinger C, Maconi G, Fearnhead NS, Kopylov U, Davidov Y, Bosca-Watts MM, Ellul P, Muscat M, Karmiris K, Hart AL, Danese S, Ben-Horin S, Fiorino G.

Aliment Pharmacol Ther. 2018 Nov;48(9):941-950. doi: 10.1111/apt.14969. Epub 2018 Sep 18.

PMID:
30226271
16.

Acceptability, effectiveness and safety of a Renew® anal insert in patients who have undergone restorative proctocolectomy with ileal pouch-anal anastomosis.

Segal JP, Leo CA, Hodgkinson JD, Cavazzoni E, Bradshaw E, Lung PFC, Ilangovan R, Vaizey CJ, Faiz OD, Hart AL, Clark SK.

Colorectal Dis. 2019 Jan;21(1):73-78. doi: 10.1111/codi.14422. Epub 2018 Oct 8.

17.

A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.

Schiff ER, Frampton M, Semplici F, Bloom SL, McCartney SA, Vega R, Lovat LB, Wood E, Hart AL, Crespi D, Furman MA, Mann S, Murray CD, Segal AW, Levine AP.

Dig Dis Sci. 2018 Nov;63(11):3049-3057. doi: 10.1007/s10620-018-5219-9. Epub 2018 Sep 3.

18.

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore D, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Williams HR, Goldenberg SD.

J Hosp Infect. 2018 Sep;100 Suppl 1:S1-S31. doi: 10.1016/j.jhin.2018.07.037. No abstract available.

19.

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore DJ, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Goldenberg SD, Williams HRT.

Gut. 2018 Nov;67(11):1920-1941. doi: 10.1136/gutjnl-2018-316818. Epub 2018 Aug 28.

20.

Indications and outcomes of home parenteral nutrition in patients with an ileoanal pouch.

Oke SM, Segal J, Clark SK, Hart AL, Gabe SM.

Ann R Coll Surg Engl. 2019 Jan;101(1):17-20. doi: 10.1308/rcsann.2018.0131. Epub 2018 Aug 16.

PMID:
30112936
21.

Challenges in screening for latent tuberculosis in inflammatory bowel disease prior to biologic treatment: a UK cohort study.

Thi AA, Abbara A, Bouri S, Collin SM, Wolfson P, Owen L, Buell KG, John L, Hart AL.

Frontline Gastroenterol. 2018 Jul;9(3):234-240. doi: 10.1136/flgastro-2017-100951. Epub 2018 Apr 4.

22.

Evolutionary history of human colitis-associated colorectal cancer.

Baker AM, Cross W, Curtius K, Al Bakir I, Choi CR, Davis HL, Temko D, Biswas S, Martinez P, Williams MJ, Lindsay JO, Feakins R, Vega R, Hayes SJ, Tomlinson IPM, McDonald SAC, Moorghen M, Silver A, East JE, Wright NA, Wang LM, Rodriguez-Justo M, Jansen M, Hart AL, Leedham SJ, Graham TA.

Gut. 2019 Jun;68(6):985-995. doi: 10.1136/gutjnl-2018-316191. Epub 2018 Jul 10.

23.

Healthcare personnel vaccination policies in michigan long-term care facilities.

Kimmins LM, Bramer CA, Chandler JL, Hart AL.

Infect Control Hosp Epidemiol. 2018 Aug;39(8):1003-1005. doi: 10.1017/ice.2018.110. Epub 2018 Jun 20.

PMID:
29921341
24.

Review article: pathogenesis of Crohn's perianal fistula-understanding factors impacting on success and failure of treatment strategies.

Tozer PJ, Lung P, Lobo AJ, Sebastian S, Brown SR, Hart AL, Fearnhead N; of ENiGMA Collaboration.

Aliment Pharmacol Ther. 2018 Aug;48(3):260-269. doi: 10.1111/apt.14814. Epub 2018 Jun 19. Review.

PMID:
29920706
25.

Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial.

Taylor SA, Mallett S, Bhatnagar G, Baldwin-Cleland R, Bloom S, Gupta A, Hamlin PJ, Hart AL, Higginson A, Jacobs I, McCartney S, Miles A, Murray CD, Plumb AA, Pollok RC, Punwani S, Quinn L, Rodriguez-Justo M, Shabir Z, Slater A, Tolan D, Travis S, Windsor A, Wylie P, Zealley I, Halligan S; METRIC study investigators.

Lancet Gastroenterol Hepatol. 2018 Aug;3(8):548-558. doi: 10.1016/S2468-1253(18)30161-4. Epub 2018 Jun 18.

26.

Innovation in the imaging perianal fistula: a step towards personalised medicine.

Sahnan K, Adegbola SO, Tozer PJ, Patel U, Ilangovan R, Warusavitarne J, Faiz OD, Hart AL, Phillips RKS, Lung PFC.

Therap Adv Gastroenterol. 2018 May 24;11:1756284818775060. doi: 10.1177/1756284818775060. eCollection 2018.

27.

Symptom amelioration in Crohn's perianal fistulas using video assisted anal fistula treatment (VAAFT).

Adegbola SO, Sahnan K, Tozer PJ, Strouhal R, Hart AL, Lung PF, Phillips RK, Faiz O, Warusavitarne J.

J Crohns Colitis. 2018 May 25. doi: 10.1093/ecco-jcc/jjy071. [Epub ahead of print]

PMID:
29800373
28.

Long-term follow-up of the use of maintenance antibiotic therapy for chronic antibiotic-dependent pouchitis.

Segal JP, Poo SX, McLaughlin SD, Faiz OD, Clark SK, Hart AL.

Frontline Gastroenterol. 2018 Apr;9(2):154-158. doi: 10.1136/flgastro-2017-100913. Epub 2018 Jan 31.

29.

Biofeedback in patients with ileoanal pouch dysfunction: a specialist centre experience.

Segal JP, Chan H, Collins B, Faiz OD, Clark SK, Hart AL.

Scand J Gastroenterol. 2018 Jun;53(6):665-669. doi: 10.1080/00365521.2018.1454508. Epub 2018 Mar 26.

30.

Developing a core outcome set for fistulising perianal Crohn's disease.

Sahnan K, Tozer PJ, Adegbola SO, Lee MJ, Heywood N, McNair AGK, Hind D, Yassin N, Lobo AJ, Brown SR, Sebastian S, Phillips RKS, Lung PFC, Faiz OD, Crook K, Blackwell S, Verjee A, Hart AL, Fearnhead NS; ENiGMA collaborators.

Gut. 2019 Feb;68(2):226-238. doi: 10.1136/gutjnl-2017-315503. Epub 2018 Feb 3.

31.

Incidence and Long-term Implications of Prepouch Ileitis: An Observational Study.

Segal JP, McLaughlin SD, Faiz OD, Hart AL, Clark SK.

Dis Colon Rectum. 2018 Apr;61(4):472-475. doi: 10.1097/DCR.0000000000000978.

PMID:
29369899
32.

Improving the Understanding of Perianal Crohn Fistula Through 3D Modeling.

Sahnan K, Adegbola SO, Tozer PJ, Gupta A, Baldwin-Cleland R, Yassin N, Warusavitarne J, Faiz OD, Hart AL, Phillips RKS, Lung PFC.

Ann Surg. 2018 Jun;267(6):e105-e107. doi: 10.1097/SLA.0000000000002629. No abstract available.

PMID:
29232211
33.

Editorial: anti-TNF therapy and myopenia in Crohn's disease-another step towards personalised medicine. Authors' reply.

Ding NS, Malietzis G, Hart AL.

Aliment Pharmacol Ther. 2018 Jan;47(1):142-143. doi: 10.1111/apt.14409. No abstract available.

34.

Systematic review: ileoanal pouch microbiota in health and disease.

Segal JP, Oke S, Hold GL, Clark SK, Faiz OD, Hart AL.

Aliment Pharmacol Ther. 2018 Feb;47(4):466-477. doi: 10.1111/apt.14454. Epub 2017 Dec 5.

35.

A Systematic Review: The Management and Outcomes of Ileal Pouch Strictures.

Segal JP, Adegbola SO, Worley GHT, Sahnan K, Tozer P, Lung PFC, Faiz OD, Clark SK, Hart AL.

J Crohns Colitis. 2018 Feb 28;12(3):369-375. doi: 10.1093/ecco-jcc/jjx151. Review.

36.

Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study.

Choi CR, Al Bakir I, Ding NJ, Lee GH, Askari A, Warusavitarne J, Moorghen M, Humphries A, Ignjatovic-Wilson A, Thomas-Gibson S, Saunders BP, Rutter MD, Graham TA, Hart AL.

Gut. 2017 Nov 17. pii: gutjnl-2017-314190. doi: 10.1136/gutjnl-2017-314190. [Epub ahead of print]

37.

Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet? Authors' reply.

Costello SP, Soo W, Bryant RV, Jairath V, Hart AL, Andrews JM.

Aliment Pharmacol Ther. 2017 Sep;46(6):631-632. doi: 10.1111/apt.14246. No abstract available.

38.

What are the dietary treatment research priorities for inflammatory bowel disease? A short report based on a priority setting partnership with the James Lind Alliance.

Lomer MC, Hart AL, Verjee A, Daly A, Solomon J, Mclaughlin J.

J Hum Nutr Diet. 2017 Dec;30(6):709-713. doi: 10.1111/jhn.12494. Epub 2017 Aug 10.

PMID:
28799179
39.

Multiorgan eosinophilic infiltration after initiation of clozapine therapy: a case report.

Marchel D, Hart AL, Keefer P, Vredeveld J.

BMC Res Notes. 2017 Jul 25;10(1):316. doi: 10.1186/s13104-017-2662-1.

40.

Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.

Costello SP, Soo W, Bryant RV, Jairath V, Hart AL, Andrews JM.

Aliment Pharmacol Ther. 2017 Aug;46(3):213-224. doi: 10.1111/apt.14173. Epub 2017 Jun 14. Review.

41.

Classifying trunk strength impairment according to the activity limitation caused in wheelchair rugby performance.

Altmann VC, Groen BE, Hart AL, Vanlandewijck YC, Keijsers NLW.

Scand J Med Sci Sports. 2018 Feb;28(2):649-657. doi: 10.1111/sms.12921. Epub 2017 Jul 13.

PMID:
28543819
42.

Pilot study of immunological factors in non-inflammatory bowel disease enterocutaneous fistulas.

Rahbour G, Warusavitarne J, Hart AL, Tozer PJ, Ullah MR, Thomas GP, Gabe SM, Knight SC, Al-Hassi HO, Vaizey CJ.

Int J Surg. 2017 May;41:127-133. doi: 10.1016/j.ijsu.2017.03.079. Epub 2017 Mar 30.

43.

Clonal evolution of colorectal cancer in IBD.

Choi CR, Bakir IA, Hart AL, Graham TA.

Nat Rev Gastroenterol Hepatol. 2017 Apr;14(4):218-229. doi: 10.1038/nrgastro.2017.1. Epub 2017 Feb 8. Review.

PMID:
28174420
44.

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.

Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P, Langner C, Limdi JK, Pellino G, Zagórowicz E, Raine T, Harbord M, Rieder F; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2017 Jun 1;11(6):649-670. doi: 10.1093/ecco-jcc/jjx008. No abstract available.

PMID:
28158501
45.

Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm.

Segal JP, Ding NS, Worley G, Mclaughlin S, Preston S, Faiz OD, Clark SK, Hart AL.

Aliment Pharmacol Ther. 2017 Mar;45(5):581-592. doi: 10.1111/apt.13905. Epub 2016 Dec 23. Review. Erratum in: Aliment Pharmacol Ther. 2018 Mar;47(6):864.

46.

The impact of trunk impairment on performance-determining activities in wheelchair rugby.

Altmann VC, Groen BE, Hart AL, Vanlandewijck YC, van Limbeek J, Keijsers NLW.

Scand J Med Sci Sports. 2017 Sep;27(9):1005-1014. doi: 10.1111/sms.12720. Epub 2016 Oct 2.

PMID:
27696507
47.

The prevalence of chronic peri-pouch sepsis in patients treated for antibiotic-dependent or refractory primary idiopathic pouchitis.

van der Ploeg VA, Maeda Y, Faiz OD, Hart AL, Clark SK.

Colorectal Dis. 2017 Sep;19(9):827-831. doi: 10.1111/codi.13536.

48.

What Are the Top 10 Research Questions in the Treatment of Inflammatory Bowel Disease? A Priority Setting Partnership with the James Lind Alliance.

Hart AL, Lomer M, Verjee A, Kemp K, Faiz O, Daly A, Solomon J, McLaughlin J.

J Crohns Colitis. 2017 Feb;11(2):204-211. doi: 10.1093/ecco-jcc/jjw144. Epub 2016 Aug 9.

49.

A review of endoscopic balloon dilatation techniques for treating Crohn's strictures: time to standardise therapy.

Arebi N, Hart AL, Thomas-Gibson S.

Expert Rev Gastroenterol Hepatol. 2016 Oct;10(10):1101-1107. doi: 10.1080/17474124.2016.1212656. Epub 2016 Jul 27.

PMID:
27411078
50.

Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer.

Landy J, Ronde E, English N, Clark SK, Hart AL, Knight SC, Ciclitira PJ, Al-Hassi HO.

World J Gastroenterol. 2016 Mar 21;22(11):3117-26. doi: 10.3748/wjg.v22.i11.3117. Review.

Supplemental Content

Support Center